Defensins are small cationic peptides produced by neutrophils and epithelial cells, playing a crucial role in the innate immune response due to their antimicrobial properties. Recent studies have linked single nucleotide polymorphisms (SNPs) in beta-defensins to an increased susceptibility to cancer. Specifically, downregulation of beta-defensins has been observed in oral cancer, indicating a potential tumor-suppressive role.
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.